Ropivacaine

Generic Name
Ropivacaine
Brand Names
Naropin
Drug Type
Small Molecule
Chemical Formula
C17H26N2O
CAS Number
84057-95-4
Unique Ingredient Identifier
7IO5LYA57N
Background

Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.

Indication

Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.

Associated Conditions
Acute Pain, Postoperative pain
Associated Therapies
Surgical anesthesia therapy
Clinical Trials
Related News

Ultrasound-guided Transmuscular Quadratus Lumborum Block for Percutaneous Nephrolithotomy

First Posted Date
2016-06-29
Last Posted Date
2018-03-22
Lead Sponsor
Zealand University Hospital
Target Recruit Count
60
Registration Number
NCT02818140

Intermittent Ropivacaine Bolus for Epidural Labor Analgesia

Completed
Conditions
Labor Pain
Interventions
Drug: Ropivacaine
First Posted Date
2016-06-22
Last Posted Date
2019-07-08
Lead Sponsor
Pierre and Marie Curie University
Target Recruit Count
500
Registration Number
NCT02809742
Locations
🇫🇷

CHU Nimes, Nimes, Gard, France

Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex)

First Posted Date
2016-06-15
Last Posted Date
2021-04-06
Lead Sponsor
Mofya Diallo
Registration Number
NCT02799589

Efficacy of Peri-Incisional Multimodal Drug Injection Following Operative Management of Femur Fractures

First Posted Date
2016-06-08
Last Posted Date
2018-04-05
Lead Sponsor
University of Iowa
Target Recruit Count
102
Registration Number
NCT02793947
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Adductor Canal Mid-thigh and Adductor Canal Distal Thigh: Is Cutaneous Sensory Blockade Similar Among Block Techniques?

Phase 4
Terminated
Conditions
Postoperative Pain
Interventions
Drug: Ropivacaine
First Posted Date
2016-06-02
Last Posted Date
2021-04-21
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
52
Registration Number
NCT02788019
Locations
🇺🇸

Zale Lipshy University Hospital, Dallas, Texas, United States

Improving Pain Relief Following Laparoscopic Ventral Hernia Repair

First Posted Date
2016-05-27
Last Posted Date
2019-09-30
Lead Sponsor
University of Auckland, New Zealand
Registration Number
NCT02785276
Locations
🇳🇿

Manukau Surgical Centre, Middlemore Hospital, Auckland, New Zealand

The Effect of Dexamedetomidine for Interscalene Brachial Plexus Block on Plasma Biomarkers After Rotator Cuff Repair

Not Applicable
Completed
Conditions
Pain
Interventions
Drug: dexmedetomidine
Drug: Ropivacaine
Procedure: ISB
First Posted Date
2016-05-10
Last Posted Date
2016-05-10
Lead Sponsor
Chuncheon Sacred Heart Hospital
Target Recruit Count
50
Registration Number
NCT02766556

Effect of Infraorbital and Infratrochlear Nerve Block on Emergence Agitation in Patients Undergoing Septorhinoplasty

First Posted Date
2016-04-26
Last Posted Date
2016-04-29
Lead Sponsor
Armed Forces Hampyeong Hospital
Target Recruit Count
66
Registration Number
NCT02751268
Locations
🇰🇷

Armed Forces Hampyeong Hospital, Geumgye-ri, Haebo-myeon, Hampyeong-gun, Jeollanam-do, Korea, Republic of

Perineural Dexamethasone in Femural Nerve Block After Ligament Reconstruction

First Posted Date
2016-04-22
Last Posted Date
2017-08-02
Lead Sponsor
Foisor Orthopedics Clinical Hospital
Target Recruit Count
90
Registration Number
NCT02749162
Locations
🇷🇴

Foisor Orthopedics Clinical Hospital, Bucharest, Romania

Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis

First Posted Date
2016-04-15
Last Posted Date
2022-01-24
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
52
Registration Number
NCT02740127
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy